Gulnara Anzarova advises health care providers and regulated businesses responding to government investigations, enforcement actions and audits involving federal and state agencies. She works with hospitals, health systems, physician groups and other providers on matters involving health care fraud and abuse enforcement, the False Claims Act, Anti-Kickback Statute, Stark Law, Medicare and Medicaid reimbursement and coverage requirements, FDA regulatory matters, Administrative Procedure Act (APA) challenges and related litigation.

Gulnara supports clients in high-stakes, time-sensitive matters involving government inquiries, internal reviews, factual record development and strategic responses to agency requests. Her work includes helping organizations address compliance challenges, manage risk and navigate evolving enforcement expectations in matters involving Medicare, Medicaid, federal benefits programs, data-driven enforcement activity and challenges to agency action under the APA.

She also assists clients with antitrust-related matters and regulatory issues involving SBA loans and other federal lending programs. Her experience includes work related to program integrity enforcement, Medicaid claims data, CMS initiatives, provider screening, enrollment scrutiny, data analytics expansion, cross-program enforcement alignment, HIPAA and Part 2 compliance issues, Medicare drug pricing models, FDA enforcement trends and federal anti-fraud priorities.

Before entering legal practice, Gulnara conducted research in tumor immunology, developing a foundation in scientific analysis and attention to detail that informs her work on complex investigations and data-driven matters.